What factors help or stop teens with Type 1 diabetes from being physically active in Istanbul

Examining Multilevel Factors Affecting Participation in Physical Activity Among Adolescents With Type 1 Diabetes Using the Socio-Ecological Model

Observational Biruni University · NCT07568028

This observational project will see how individual, family, school, community, and policy-level factors relate to physical activity, social participation, and diabetes management in adolescents (9–18 years) with Type 1 diabetes who attend school in Istanbul.

Quick facts

Study typeObservational
Enrollment55 (estimated)
Ages9 Years to 18 Years
SexAll
SponsorBiruni University Academic / other
Locations1 site (Istanbul, Zeytinburnu)
Trial IDNCT07568028 on ClinicalTrials.gov

What this trial studies

Participants with Type 1 diabetes who meet inclusion criteria will complete standardized questionnaires about their physical activity, social participation, diabetes self-management, and relevant individual and environmental influences framed by the Socio-Ecological Model. Data collection focuses on multilevel domains: individual, interpersonal, institutional (school), community, and policy factors, together with reported glucose biomarkers and recent HbA1c. The study is observational and based at Biruni University in Zeytinburnu, recruiting school-attending adolescents using at least one glucose monitoring device and with HbA1c ≥ 8% within the past year. Analyses will identify modifiable barriers and facilitators associated with higher or lower levels of physical activity and related outcomes.

Who should consider this trial

Good fit: Ideal candidates are school-attending adolescents aged 9–18 in Istanbul with a diagnosis of Type 1 diabetes for at least one year, recent HbA1c ≥ 8%, reported glucose monitoring data, cognitive ability to complete questionnaires, and willingness to provide consent.

Not a fit: Patients unlikely to benefit include those outside the Istanbul school-attending population, with HbA1c < 8% or missing HbA1c data, with significant neurological/motor/cognitive disorders or systemic comorbidities, or those unable to complete questionnaires.

Why it matters

Potential benefit: If successful, the findings could point to modifiable barriers and supports that help increase physical activity and improve diabetes management for adolescents with Type 1 diabetes.

How similar studies have performed: Previous research indicates that multilevel factors influence physical activity in youth with Type 1 diabetes, but comprehensive SEM-centered, school-based data from Istanbul are limited.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with Type 1 diabetes at least 1 year prior to enrollment,
* Aged between 9 and 18 years,
* Currently attending school in Istanbul,
* Willing to participate in the study (with voluntary consent),
* HbA1c value ≥ 8% within the past year,
* Reported glucose metabolism biomarkers,
* Sufficient cognitive ability to understand and complete the questionnaires,
* Under regular medical follow-up and using at least one glucose monitoring device.

Exclusion Criteria:

* Lack of parental consent,
* Presence of additional neurological, motor, or cognitive disorders,
* Inadequate mental status or diagnosis of moderate to severe intellectual disability,
* Presence of systemic comorbid diseases,
* Failure to report HbA1c data.

Where this trial is running

Istanbul, Zeytinburnu

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Type 1 Diabetes MellitusType 1 diabetes mellitusSocio-Ecological ModelPhysical Activity
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.